Menu
Recruiting NCT06911996

The WOW Project (WOW): Wonders Of The World Through Virtual Reality for Hospitalized Children

No phase Interventional Virtual Reality

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Virtual Reality.
Who it may be relevant to
Registry conditions: Virtual Reality. Basic parameters: 5 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Immersive Bedside Teaching for Hospitalized Pediatric Patient - A Prospective, Mixed-method, Cohort Study

Overview

Hospitalized pediatric patients are unable to leave the hospital to engage in traditional learning environments. Patients often feel depressed, disconnected from learning, and socially withdrawn. The Stanford Chariot Program proposes a partnership with the Palo Alto Unified Hospital School at Stanford Children's Health to reignite patients' emotional well-being through learning. The WOW Project aims to use virtual reality (VR) to travel with hospitalized children to the Wonders of the World (WOW). Combining this immersive learning modality with complementary hands-on activities at the bedside, the investigators will transport them from their hospital room into a nurturing virtual environment to stimulate their emotional, mental, and social growth while they are physically healing. The investigators will evaluate their overall joy and awe of learning by using standardized emotional scales.

Interventions

  • Behavioral Virtual Reality
    After obtaining written consent, participants will be asked to complete a brief demographic survey and pre-intervention surveys (content knowledge, and wellbeing surveys). They will then be equipped with a VR headset, Quest 3 (Meta, Inc., Menlo Park, CA) displaying the educational field trip. After the VR field trip, participants will participate in a complementary hands-on science experiment. At the conclusion of the experiment, patients will be asked to complete the post intervention surveys (

Primary outcome measures

  • Assess the impact of VR-based field trips on the feeling of awe of the pediatric inpatient population [Time frame: immediately after intervention]
Secondary outcome measures (3)
  • Change in the number of correct answers of the content knowledge [Time frame: Day 1 baseline, Day 1 immediately after intervention]
  • Change in a patients' well-being as measured through the World Health Organization-Five Well-Being Index (WHO-5) [Time frame: Day 1 baseline, Day 1 immediately after intervention]
  • Thematic analysis of the qualitative surveys including how the lesson engagement correlates to the increase in joyful learning. [Time frame: immediately after intervention]

Eligibility criteria

Inclusion criteria

  • Between the age of 5 and 17.
  • English speaking.
  • Anticipated in-patient stay for more than 1 day.

Exclusion criteria

  • Legal guardian not present to obtain consent
  • Child with a significant neurological condition, or major developmental disability
  • Child with active infection of the face or hand
  • A history of severe motion sickness
  • A history of seizures caused by flashing light
  • Major surgery within the last 12 hours

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Lucile Packard Children's Hospital Stanford — Palo Alto

Identifiers

NCT: NCT06911996 · 80079

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗